EUR 11.94
(5.29%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.78 Billion EUR | 10.8% |
2022 | 1.61 Billion EUR | 18.67% |
2021 | 1.35 Billion EUR | 116.65% |
2020 | 626.54 Million EUR | 21.23% |
2019 | 516.8 Million EUR | 57.64% |
2018 | 327.82 Million EUR | 29.25% |
2017 | 253.63 Million EUR | 90.4% |
2016 | 133.21 Million EUR | 98865053.63% |
2015 | 134.74 EUR | -96.99% |
2014 | 4483.76 EUR | 1274.92% |
2013 | 326.11 EUR | -99.07% |
2012 | 35.22 Thousand EUR | -97.44% |
2011 | 1.37 Million EUR | 32.52% |
2010 | 1.03 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 456.22 Million EUR | 3.39% |
2024 Q2 | 451.03 Million EUR | -1.14% |
2023 Q4 | 441.24 Million EUR | -9.94% |
2023 Q3 | 489.94 Million EUR | 16.02% |
2023 FY | 1.78 Billion EUR | 10.8% |
2023 Q1 | 431.23 Million EUR | 7.98% |
2023 Q2 | 422.27 Million EUR | -2.08% |
2022 Q1 | 392.95 Million EUR | 6.59% |
2022 Q2 | 399.22 Million EUR | 1.6% |
2022 FY | 1.61 Billion EUR | 18.67% |
2022 Q3 | 419.21 Million EUR | 5.01% |
2022 Q4 | 399.38 Million EUR | -4.73% |
2021 Q3 | 353.83 Million EUR | 10.91% |
2021 Q1 | 315.9 Million EUR | 81.93% |
2021 Q4 | 368.64 Million EUR | 4.18% |
2021 FY | 1.35 Billion EUR | 116.65% |
2021 Q2 | 319.01 Million EUR | 0.98% |
2020 Q3 | 160.01 Million EUR | 23.04% |
2020 Q2 | 130.05 Million EUR | -20.13% |
2020 Q1 | 162.83 Million EUR | 12.2% |
2020 Q4 | 173.64 Million EUR | 8.52% |
2020 FY | 626.54 Million EUR | 21.23% |
2019 Q3 | 143.17 Million EUR | 17.6% |
2019 Q1 | 114.46 Million EUR | 24.54% |
2019 FY | 516.8 Million EUR | 57.64% |
2019 Q4 | 145.12 Million EUR | 1.36% |
2019 Q2 | 121.74 Million EUR | 6.36% |
2018 Q3 | 91.91 Million EUR | 26.82% |
2018 FY | 327.82 Million EUR | 29.25% |
2018 Q2 | 72.47 Million EUR | -0.0% |
2018 Q1 | 72.47 Million EUR | 5.97% |
2018 Q4 | 91.91 Million EUR | 0.0% |
2017 FY | 253.63 Million EUR | 90.4% |
2017 Q1 | 58.67 Million EUR | 55.04% |
2017 Q2 | 58.67 Million EUR | -0.0% |
2017 Q3 | 68.39 Million EUR | 16.57% |
2017 Q4 | 68.39 Million EUR | 0.0% |
2016 Q4 | 37.84 Million EUR | 0.0% |
2016 Q1 | 28.76 Million EUR | 0.0% |
2016 Q2 | 28.76 Million EUR | -0.0% |
2016 Q3 | 37.84 Million EUR | 31.58% |
2016 FY | 133.21 Million EUR | 98865053.63% |
2015 FY | 134.74 EUR | -96.99% |
2014 FY | 4483.76 EUR | 1274.92% |
2013 FY | 326.11 EUR | -99.07% |
2012 FY | 35.22 Thousand EUR | -97.44% |
2011 FY | 1.37 Million EUR | 32.52% |
2010 FY | 1.03 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Cegedim SA | 615.99 Million EUR | -189.727% |
Guerbet SA | 795.65 Million EUR | -124.306% |
Nexus AG | 241.45 Million EUR | -639.133% |
Bastide Le Confort Médical SA | 529.75 Million EUR | -236.892% |
Revenio Group Oyj | 96.57 Million EUR | -1747.978% |
Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 47.096% |
Sartorius Aktiengesellschaft | 3.39 Billion EUR | 47.442% |
LNA Santé SA | 736.08 Million EUR | -142.459% |
Siemens Healthineers AG | 22.36 Billion EUR | 92.019% |
Equasens Société anonyme | 219.78 Million EUR | -712.011% |
Stratec SE | 261.91 Million EUR | -581.416% |